Controversies and unresolved issues in tuberculosis prevention and control: a low-burden-country perspective (Q39636742)

13 September 2017

title

Controversies and unresolved issues in tuberculosis prevention and control: a low-burden-country perspective (English)

1 reference

13 September 2017

0 references

1

1 reference

13 September 2017

9

1 reference

13 September 2017

Helen R Stagg

2

0 references

Laura C Rodrigues

object named as

Laura C Rodrigues

5

0 references

Stephen Squire

object named as

S Bertel Squire

8

0 references

author name string

Ted Cohen

3

1 reference

13 September 2017

Punam Mangtani

4

1 reference

13 September 2017

Laura Pimpin

6

1 reference

13 September 2017

John M Watson

7

1 reference

13 September 2017

language of work or name

English

0 references

publication date

22 March 2012

1 reference

Journal of Infectious Diseases

13 September 2017

published in

1 reference

13 September 2017

volume

205 Suppl 2

1 reference

13 September 2017

page(s)

S293-300

1 reference

Tuberculosis in the UK--time to regain control

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Tuberculosis in London: the importance of homelessness, problem drug use and prison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Tuberculosis and homelessness in the United States, 1994-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Emergent heterogeneity in declining tuberculosis epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Tuberculosis in New York City--turning the tide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

The historical decline of tuberculosis in Europe and America: its causes and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Variation in protection by BCG: implications of and for heterologous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

The BCG World Atlas: a database of global BCG vaccination policies and practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

How does the level of BCG vaccine protection against tuberculosis fall over time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Fact and fiction in tuberculosis vaccine research: 10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Domestic returns from investment in the control of tuberculosis in other countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Cost-effectiveness of tuberculosis control strategies among immigrants and refugees

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Chest roentgenogram in pulmonary tuberculosis. New data on an old test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

The incidence of false-positive cultures for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Overseas screening for tuberculosis in U.S.-bound immigrants and refugees

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

The role of entry screening in case finding of tuberculosis among asylum seekers in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Impact of mobile radiographic screening on tuberculosis among drug users and homeless persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Tuberculosis in New York city: recent lessons and a look ahead.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Human gene expression profiles of susceptibility and resistance in tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Three months of rifapentine and isoniazid for latent tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Preventive therapy for contacts of multidrug-resistant tuberculosis. A Delphi survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Treatment of latent tuberculosis infection: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

Epidemiology of urban tuberculosis in the United States, 2000-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR886

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIR886

1 reference

release_wjmeqiafqfhgfdybiow44r3q4i

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wjmeqiafqfhgfdybiow44r3q4i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference